Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 30;8(6):1399.
doi: 10.4022/jafib.1399. eCollection 2016 Apr-May.

First And Second-Generation Cryoballoon Ablation Efficacy Restoring And Maintaining Sinus Rhythm In Patients Electrically Selected And Treated For Long-Standing Persistent Atrial Fibrillation After Acute Complete Electrical Disconnection Of Pulmonary Veins From The Left Atrium Demonstrated

Affiliations

First And Second-Generation Cryoballoon Ablation Efficacy Restoring And Maintaining Sinus Rhythm In Patients Electrically Selected And Treated For Long-Standing Persistent Atrial Fibrillation After Acute Complete Electrical Disconnection Of Pulmonary Veins From The Left Atrium Demonstrated

Jesus M Paylos et al. J Atr Fibrillation. .

Abstract

Introduction Cryoballoon ablation (CB) has proven effective to treatment of patients (pts) with atrial fibrillation (AF). However, the isolated efficacy of CB to treat pts with long-standing persistent atrial fibrillation (LSPAF) is less know. We analyzed the acute results and the long-term follow-up of our pts suffering LSPAF and initially treated with CB. Methods A cohort of 44 pts, 37 male (84%) mean age (60±10 year) suffering LSPAF were treated with first (CB1): 15pts, and second (CB2): 29 pts, generation CB. Eight pts (18.1%) had structural heart disease. Prior to CB, all pts were previously electrically cardioverted (CV) and sinus node and A-V nodal function evaluated at electrophysiological study (EP) once in sinus rhythm (SR) before antiarrhythmic drugs (AAD) load. CB ablation procedure was performed after three months waiting period on AAD following CV/EP drug testing. Result CB procedure was performed in 27 (61.4%) in AF, restoring SR in 8 (18.2%). PV isolation (PVI) was achieved in 95.2%. On follow-up of 30±39 months, 16 pts (40%) had AF recurrence. Second procedure (Redo) was performed in 7 pts. After a single procedure, 24 pts (60%) remain in SR without AAD, after Redo, 29 pts (72.5%), and when AAD added, 31 pts (77.5%) remain in SR. Phrenic nerve palsy (PNP) occurred in 9% of pts (75% with CB2). Conclusion CB technique is safe and useful tool to treat pts with LSPAF with 60% success rate maintaining SR without AAD in a long-term follow-up (30±39 months), up to 72.5% after Redo, and to 77.5% when AAD are added. In the majority of pts maintaining SR (77.5%) CB2 was used in 87% of the cases. Patients without structural heart disease along with those who SR was restored during CB showed the best result.

Keywords: Ablation; Cryoballoon; Long-Standing Atrial Fibrillation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. AF reversion/during CB application 8/27 AF pts (29.6 %)
Figure 2
Figure 2. CB1-CB2 applications: degree of occlusions and mean nadir temperature reached

Similar articles

References

    1. Van Belle Yves, Janse Petter, Rivero-Ayerza Maximo J, Thornton Andrew S, Jessurun Emile R, Theuns Dominic, Jordaens Luc. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur. Heart J. 2007 Sep;28 (18):2231–7. - PubMed
    1. Neumann Thomas, Vogt Jürgen, Schumacher Burghard, Dorszewski Anja, Kuniss Malte, Neuser Hans, Kurzidim Klaus, Berkowitsch Alexander, Koller Marcus, Heintze Johannes, Scholz Ursula, Wetzel Ulrike, Schneider Michael A E, Horstkotte Dieter, Hamm Christian W, Pitschner Heinz-Friedrich. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J. Am. Coll. Cardiol. 2008 Jul 22;52 (4):273–8. - PubMed
    1. Vogt Jürgen, Heintze Johannes, Gutleben Klaus J, Muntean Bogdan, Horstkotte Dieter, Nölker Georg. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J. Am. Coll. Cardiol. 2013 Apr 23;61 (16):1707–12. - PubMed
    1. Packer Douglas L, Kowal Robert C, Wheelan Kevin R, Irwin James M, Champagne Jean, Guerra Peter G, Dubuc Marc, Reddy Vivek, Nelson Linda, Holcomb Richard G, Lehmann John W, Ruskin Jeremy N. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J. Am. Coll. Cardiol. 2013 Apr 23;61 (16):1713–23. - PubMed
    1. Di Giovanni Giacomo, Wauters Kristel, Chierchia Gian-Battista, Sieira Juan, Levinstein Moises, Conte Giulio, de Asmundis Carlo, Baltogiannis Giannis, Saitoh Yukio, Ciconte Giuseppe, Julia Justo, Mugnai Giacomo, Irfan Ghazala, Brugada Pedro. One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. J. Cardiovasc. Electrophysiol. 2014 Aug;25 (8):834–9. - PubMed

LinkOut - more resources